What's new

Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 25, Status: Authorised

Feb 14, 2025 - 16:58
 0
Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 25, Status: Authorised
Read More

Tags:

Previous Article

Opinion/decision on a Paediatric investigation plan (PIP): Enerzair Breezhaler, ...

Next Article

EMEA-003467-PIP01-23

Related Posts

Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 4, 2025  0

Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 02/05/2014, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 24, 2025  0

Herbal medicinal product: Valerianae aetheroleumArray, F: Assessment finalised

Herbal medicinal product: Valerianae aetheroleumArray, ...

Feb 14, 2025  0